Trump Announces Major Expansion of Drug Pricing Plan
A surprising fact stands out from the latest news on drug costs. Nine out of ten drugs used by Americans are now covered by agreements made under President Trump's pricing plan. This shift happened quickly after nine more companies signed on to the deal. President Trump announced the expansion from the Oval Office on Monday. The new partners include major names like Alcon, Teva Pharmaceuticals, and UCB. These companies now join a total of 26 drugmakers working under the "most favored nation" system.
The plan forces companies to charge Americans the lowest price other rich nations pay. This covers medicines for seizures, infections, and organ transplants. It also helps people with Parkinson's disease, cancer, and liver issues.
U.S. patients currently pay nearly three times as much as people in other developed countries. That gap is finally closing thanks to these new contracts. The White House expects these deals to save Americans more than $600 billion over the next decade. Manufacturers also agreed to offer these lower prices to state Medicaid programs. This means tax dollars will stretch further for state health budgets. The savings apply to both cash buyers and those covered by government insurance. President Trump made it clear he wants these changes to last forever. "We want to make it permanent," Mr. Trump said of his company-by-company pricing deals, according to the Washington Times. He added that Congress should approve the rules to lock them in.
The President warned that future leaders might try to undo these hard-won gains. He said he could not To stop this, he pushed for the agreements to be written into law.
"It's still a good idea to have it codified, to have it approved by Congress," he said. Without this step, the deals could fall apart when political winds change. The threat of 100 percent tariffs on imported drugs helped pressure companies to sign.
Trump has been leaning on manufacturers to close the price gap. He backed that pressure with a credible threat of national security investigations. Now, the system works for the patient, not just the corporate bottom line.
This is a win for families who pay cash for their prescriptions. The discounts are available directly on the TrumpRx website for uninsured buyers. Mr. Trump noted he deserves credit for these historic decreases. He announced the deals as a major expansion of a signature affordability initiative. "Today brings us to a total of 26 companies that have now made agreements with us. These agreements cover nine out of 10 drugs that are used by Americans."
The system ensures new medicines will also follow these fair pricing rules. This prevents drugmakers from hiking prices on new cures later. The result is a stable market that respects the American worker.